New FDA Policy May Speed Biosimilar Insulins to US Market New FDA Policy May Speed Biosimilar Insulins to US Market

But the new guidance may not have a big impact on price, despite the agency ' s pronouncements.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news